Browsing: Pharmaceutical CDMO
4 weeks ago
Windlas Biotech Q2 Results: EBITDA Margin Shows Slight Improvement
- Indian Markets
- Block Deals
- Commodities
- Earnings Reports
- Global Insights
- Investing
- Bonds
- Market Analysis
- Special coverage
Recent Posts
- NSE Index Closes 0.24% Lower, Drops 58.80 Points to 24,619.00
- Datamatics Global Services: Subsidiary to Acquire 100% Stake in TNQ Tech with Initial Payment of ₹3.36 Billion
- Tata Motors to Increase Passenger Vehicle Prices by Up to 3% from January 2025
- VPRPL Secures ₹1.03 Billion Contract from North Western Railway, Ajmer Division
- CE Info Systems Reverses Decision to Invest in New Company